keratoacanthoma (Cancer)
Information
- Disease name
- keratoacanthoma
- Disease ID
- DOID:3149
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02978625 | Active, not recruiting | Phase 2 | Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers | September 27, 2017 | September 1, 2025 |
| NCT03630198 | Completed | Phase 4 | Pain Outcomes Following Intralesional Corticosteroid Injections | October 1, 2018 | September 1, 2019 |
| NCT03714828 | Completed | Phase 2 | Study of TVEC in Patients With Cutaneous Squamous Cell Cancer | December 20, 2018 | July 19, 2023 |
- Disase is a (Disease Ontology)
- DOID:3151
- Cross Reference ID (Disease Ontology)
- MESH:D007636
- Cross Reference ID (Disease Ontology)
- NCI:C3146
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:201061007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0022572
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0031525
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007636